Ciro Longobardi

789 total citations
14 papers, 514 citations indexed

About

Ciro Longobardi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Ciro Longobardi has authored 14 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Cancer Research. Recurrent topics in Ciro Longobardi's work include Colorectal Cancer Treatments and Studies (8 papers), Gastric Cancer Management and Outcomes (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). Ciro Longobardi is often cited by papers focused on Colorectal Cancer Treatments and Studies (8 papers), Gastric Cancer Management and Outcomes (3 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). Ciro Longobardi collaborates with scholars based in Italy, Netherlands and France. Ciro Longobardi's co-authors include Michael Hahne, Jan Paul Medema, Andrea Martoni, C. Funaioli, Carmine Pinto, Francesca Di Fabio, S. Giaquinta, Fabiola Lorena Rojas Llimpe, V. Mutri and Claudio Ceccarelli and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Ciro Longobardi

14 papers receiving 501 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ciro Longobardi Italy	8	306	276	133	104	85	14	514
Margherita Pinto Italy	8	338 1.1×	308 1.1×	153 1.2×	178 1.7×	45 0.5×	10	566
Guanghai Dai China	13	359 1.2×	354 1.3×	168 1.3×	183 1.8×	118 1.4×	34	670
Adrian Goldiș Romania	11	146 0.5×	157 0.6×	133 1.0×	110 1.1×	91 1.1×	27	408
Yuichi Hisamatsu Japan	15	277 0.9×	194 0.7×	211 1.6×	156 1.5×	128 1.5×	33	631
Daniele Lavacchi Italy	12	303 1.0×	184 0.7×	124 0.9×	75 0.7×	85 1.0×	46	476
Alexander G. Raufi United States	11	275 0.9×	140 0.5×	156 1.2×	111 1.1×	125 1.5×	36	457
David Borg Sweden	12	391 1.3×	177 0.6×	194 1.5×	164 1.6×	131 1.5×	20	617
Akiko Kawano Nagatsuma Japan	12	381 1.2×	387 1.4×	164 1.2×	153 1.5×	92 1.1×	16	653
Luckson Mathieu United States	8	290 0.9×	254 0.9×	157 1.2×	87 0.8×	75 0.9×	12	526
Peter Cheverton United Kingdom	11	313 1.0×	137 0.5×	245 1.8×	58 0.6×	46 0.5×	18	529

Countries citing papers authored by Ciro Longobardi

Since Specialization

Citations

This map shows the geographic impact of Ciro Longobardi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ciro Longobardi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ciro Longobardi more than expected).

Fields of papers citing papers by Ciro Longobardi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ciro Longobardi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ciro Longobardi. The network helps show where Ciro Longobardi may publish in the future.

Co-authorship network of co-authors of Ciro Longobardi

This figure shows the co-authorship network connecting the top 25 collaborators of Ciro Longobardi. A scholar is included among the top collaborators of Ciro Longobardi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ciro Longobardi. Ciro Longobardi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Longobardi, Ciro, et al.. (2024). A Method to Study Migration and Invasion of Mouse Intestinal Organoids. SHILAP Revista de lepidopterología. 3(3). 194–202. 1 indexed citations

Buikhuisen, Joyce Y., Kate Cameron, Saskia J.E. Suijkerbuijk, et al.. (2023). Subtype-specific kinase dependency regulates growth and metastasis of poor-prognosis mesenchymal colorectal cancer. Journal of Experimental & Clinical Cancer Research. 42(1). 56–56. 4 indexed citations

Zwager, Liselotte W., Pim J. Koelink, Jan Köster, et al.. (2023). Consensus molecular subtype transition during progression of colorectal cancer. The Journal of Pathology. 261(3). 298–308. 3 indexed citations

Benítez, Jorge A., Darren Finlay, Anthony S. Castanza, et al.. (2021). PTEN deficiency leads to proteasome addiction: a novel vulnerability in glioblastoma. Neuro-Oncology. 23(7). 1072–1086. 31 indexed citations

Lemmers, Bénédicte, Ciro Longobardi, Valérie Pinet, et al.. (2021). The HSP90/R2TP assembly chaperone promotes cell proliferation in the intestinal epithelium. Nature Communications. 12(1). 4810–4810. 13 indexed citations

Longobardi, Ciro, et al.. (2021). The Role of Cancer-Associated Fibroblasts in Cancer Invasion and Metastasis. Cancers. 13(18). 4720–4720. 152 indexed citations

Brandi, Giovanni, Jody Corbelli, Francesco De Rosa, et al.. (2012). Second surgery or chemotherapy for relapse after radical resection of colorectal cancer metastases. Langenbeck s Archives of Surgery. 397(7). 1069–1077. 12 indexed citations

Brandi, Giovanni, Stefania Di Girolamo, Francesca Rosa, et al.. (2011). Second-line chemotherapy in patients with biliary tract cancer.. Journal of Clinical Oncology. 29(15_suppl). e14590–e14590. 7 indexed citations

Funaioli, C., Ciro Longobardi, & Andrea Martoni. (2008). The Impact of Chemotherapy on Overall Survival and Quality of Life of Patients with Metastatic Colorectal Cancer: A Review of Phase III Trials. Journal of Chemotherapy. 20(1). 14–27. 14 indexed citations

10.

Funaioli, C., Carmine Pinto, Francesca Di Fabio, et al.. (2007). 18FDG-PET Evaluation Correlates Better than CT with Pathological Response in a Metastatic Colon Cancer Patient Treated with Bevacizumab-Based Therapy. Tumori Journal. 93(6). 611–615. 8 indexed citations

11.

Fabio, Francesca Di, Carmine Pinto, Fabiola Lorena Rojas Llimpe, et al.. (2007). The predictive value of 18F-FDG-PET early evaluation in patients with metastatic gastric adenocarcinoma treated with chemotherapy plus cetuximab. Gastric Cancer. 10(4). 221–227. 43 indexed citations

12.

Pinto, Carmine, Francesca Di Fabio, Salvatore Siena, et al.. (2006). Phase II study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma (FOLCETUX study). Annals of Oncology. 18(3). 510–517. 223 indexed citations

13.

Pinto, Carmine, Claudio Ceccarelli, Francesca Di Fabio, et al.. (2006). Impact of biomarker dynamic profile and pathological response induced by neoadjuvant chemoradiotherapy in rectal cancer. Journal of Clinical Oncology. 24(18_suppl). 3614–3614. 1 indexed citations

14.

Coppola, Antonio, et al.. (1989). [Etiopathogenetic aspects of central diabetes insipidus. Report of a clinical case].. PubMed. 80(10). 1119–24. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact